Tian'an Technology TANAF
OTC TANAF
$0.09 -0.06 (-40.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Tian'an Technology (TANAF) Debt Ratio (2021 - 2026)

Updated

Tian'an Technology's (TANAF) Debt Ratio stood at 0.22 in the quarter ended Jun 30, 2026, up 271.5% from 0.06 a year earlier.

Analysis

Tian'an Technology (TANAF) Debt Ratio (2021 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Tian'an Technology's Debt Ratio came in at 0.14, up 43.7% from the prior year.

  • Across earlier years, Debt Ratio came in at 0.10 in the year ended Dec 31, 2024 (-84.6%), 0.62 in the year ended Dec 31, 2023 and 1.40 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Debt Ratio since the quarter ended Dec 31, 2023.
  • On a year-over-year basis, Debt Ratio rose in two of the last four quarters, with growth averaging 42.2%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 0.38
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 0.30
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 0.29
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 0.30
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 0.31
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 0.28
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 0.04
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 0.33
10 Tian'an Technology 4.10 Mn 3.77 Mn - 0.22
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.22
Dec 31, 2025 0.14
Jun 30, 2025 0.06
Dec 31, 2024 0.10
Jun 30, 2024 0.15
Dec 31, 2023 0.62
Dec 31, 2021 1.40
API Access

Tian'an Technology Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TANAF&period=max&api_key=YOUR_API_KEY